Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pacira BioSciences, Inc. - Common Stock
(NQ:
PCRX
)
22.17
+0.58 (+2.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pacira BioSciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2021
July 26, 2021
Upgrades Tudor Pickering upgraded the previous rating for Precision Drilling Corp (NYSE:
Via
Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Pacira BioSciences' Exparel Misses Primary Endpoint In Post-Op Pain Study After Lower Extremity Surgeries
May 26, 2021
Pacira BioSciences Inc (NASDAQ: PCRX) has announced topline results from its Phase 3 STRIDE study evaluating Exparel administered as combined sciatic (in popliteal...
Via
Benzinga
Heron's Non-Opioid, Post-Operative Pain Drug Approved By FDA: Why This Is Important
May 13, 2021
Shares of Heron Therapeutics Inc (NASDAQ: HRTX) are higher after a long wait to get regulatory approval for its non-opioid pain drug. What Happened: San Diego,...
Via
Benzinga
Pacira BioSciences, Inc. (PCRX) Q1 2021 Earnings Call Transcript
May 04, 2021
PCRX earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates
May 01, 2021
Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid...
Via
Benzinga
The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data
May 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Earnings Scheduled For May 4, 2021
May 04, 2021
Companies Reporting Before The Bell • Lancaster Colony (NASDAQ:LANC) is likely to report quarterly earnings at $1.24 per share on revenue of $340.02 million. •...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 27, 2021
Gainers BioVie (NASDAQ:BIVI) shares rose 11.62% to $24.0 during Tuesday's after-market session. Today's trading volume for this security ended up closing at 27.3K shares,...
Via
Benzinga
The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split
April 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14) 10x Genomics, Inc. (NASDAQ...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 9, 2021
April 09, 2021
Upgrades For Assertio Holdings Inc (NASDAQ:ASRT), Gabelli & Co. upgraded the previous rating of Hold to Buy. The current stock performance of Assertio Holdings shows a...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.